Similar articles

• Tissue-type plasminogen activator for acute coronary thrombosis.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 1987 Dec 4;29(754):107-9. Med Lett Drugs Ther. 1987. PMID: 3119965 Clinical Trial. No abstract available.
• Coronary thrombolysis with clot-selective plasminogen activators.

  Collen D, Bounameaux H. Collen D, et al. Herz. 1986 Feb;11(1):9-15. Herz. 1986. PMID: 3082731
• Clot-selective thrombolysis: the impact of tissue-type plasminogen activator (t-PA) in thromboembolic diseases.

  Bounameaux H. Bounameaux H. Vasa. 1986;15(2):115-8. Vasa. 1986. PMID: 3088866 No abstract available.
• [New thrombolytic agents in myocardial infarction].

  Charbonnier B, Lang M, Brochier M. Charbonnier B, et al. Arch Mal Coeur Vaiss. 1987 Nov;80(12):1785-91. Arch Mal Coeur Vaiss. 1987. PMID: 3128222 Review. French.
• Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.

  Collen D. Collen D. Prog Hemost Thromb. 1986;8:1-18. Prog Hemost Thromb. 1986. PMID: 3104986 Review. No abstract available.